Meeting
2011 ASCO Annual Meeting
Final analysis of the NEOMET trial of neoadjuvant metformin: Examining effects on Ki67, gene expression, and pathway analysis in primary operable breast cancer.
Authors
A. M. Thompson
University of Dundee, Dundee, United Kingdom
A. M. Thompson , T. Iwamoto , L. Jordan , C. Purdie , S. E. Bray , L. Baker , G. Hardie , L. Pusztai , S. L. Moulder , J. A. Dewar , S. M. Hadad
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 29: 2011 (suppl; abstr 534)
Abstract #
534
Poster Bd #
23
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2024 ASCO Annual Meeting
Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.
First Author: Murtaza Ahmed
Poster
2023 ASCO Annual Meeting
Comprehensive characterization of androgen receptor expression in breast cancer.
First Author: Priya Jayachandran
Poster
2023 ASCO Annual Meeting
Utility of multi-gene panel-based germline analysis following genomic profiling and cascade testing in advanced solid tumors: An initial report of the BRANCH study.
First Author: Takeshi Kuwata